Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 19 Neoplasms 12 Colorectal Neoplasms 5 Pain, Postoperative 4 Fatigue 4 Thyroid Neoplasms 3 Stomatitis 3 Pain 3 Malnutrition 3 Liver Neoplasms 3 Depression 3 Carcinoma, Hepatocellular 3 Anxiety Disorders 3 Stomach Neoplasms 2 Sleep Initiation and Maintenance Disorders 2 Polycystic Ovary Syndrome 2 Parasomnias 2 Motor Activity 2 Lung Neoplasms 2 Gastrointestinal Neoplasms 2 Breast Cancer Female 2 Agnosia 2 Weight Loss 1 Vomiting 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Incontinence 1 Unilateral U/S PVB 1 Ulcer 1

Interventions

Itraconazole 2 roniciclib 1 anetumab ravtansine 1 Control Groups 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Medical Oncology × Control Groups × Clear all

NCT02645357 2017-02-09

ONCO-CODES

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Phase NA Completed

15,431 enrolled

Medical Oncology

Data powered by HemOnc (CC BY 4.0) Colophon ⚡